The metabolic syndrome is being increasingly recognized as an important risk factor for cardiovascular disease (CVD). While several clinical definitions have been proposed to identify patients with this syndrome, additional metabolic markers may be considered to improve one's ability to assess and predict the risk of CVD in this population. The objective of this short review is to provide an overview of the risk of CVD associated with specific features of the metabolic syndrome. The extent to which these markers may be used one day in clinical practice in primary prevention is also briefly discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/13547500500216579 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!